Adjunct Professor

Department of Health Services
UCLA School of Public Health

President and CEO, Founder
Health Benchmarks, Inc.

Dr. Legorreta's work has contributed significantly to the development of real-world outcomes research, quality of care metrics and other cost-effective analysis. His current projects with the managed care and pharmaceutical industries include: health and pharmaceutical economics, health care demand, and assessment of new medical technology. Dr. Legorreta has developed and implemented health services research applications to measure medical care and resource consumption disparities, and has implemented quality improvement projects for the leading health plans and employers throughout the country. Dr. Legorreta's research in trauma care reimbursement was utilized to modify the categorization and reimbursement for the Major Significant Trauma DRGs in the state of New York. Dr. Legorreta has extensive experience in developing and implementing performance-based reimbursement models, which have been adopted by leading national payers. Dr. Legorreta has published original research -breast cancer, asthma, diabetes, cardiovascular disease, among other topics- in over 50 peer-reviewed medical journals, including the Journal of the American Medical Association, Archives of Internal Medicine, Diabetes Care, Annals of Allergy, Asthma and Immunology and the American Journal of Public Health. In addition to his medical training at Mexico State University School of Medicine, Dr. Legorreta earned his master's degree in public health from the Yale University School of Medicine, Division of Health Services Research. Dr. Legorreta was Visiting Assistant Clinical Professor at Mount Sinai School of Medicine, New York and he is currently an Adjunct Associate Professor at UCLA's School of Public Health. Dr. Legorreta has held Senior Executive positions at U.S. Healthcare, Health Systems International and Health Net, Inc. In 1999, Dr. Legorreta founded and incorporated Health Benchmarks Inc. (HBI) as a wholly-owned subsidiary of Health Net Inc. and in August of 2001, Dr. Legorreta completed the divestiture and acquisition of HBI. HBI's clients include among others, WellPoint, Blue Cross and Blue Shield health plans, Ford Motor Co., GlaxoSmithKline, Amgen, Eli Lilly, and Pharmacia.

Selected Publications

1. Legorreta AP, Silber JH, Costantino GN, Kobylinski RW, Zatz SL. Increased Cholecystectomy Rate After the Introduction of Laparoscopic Cholecystectomy. The Journal of the American Medical Association 1993; 270: 429-1432.

2. Sennett C, Legorreta AP, Zatz SL. Performance-based Hospital Contracting for Quality Improvement. The Joint Commission Journal on Quality Improvement 1993; 19(9): 374-383.

3. Solin LJ, Legorreta A, Schultz DJ, Zatz S, Goodman RL. The Importance of Mammographic Screening Relative to the Treatment of Women With Carcinoma of the Breast. Archives of Internal Medicine 1994; 154: 745-752.

4. Jatulis DE, Bundek NI, Legorreta AP. Identifying Predictors of Satisfaction with Access to Medical Care and Quality of Care. American Journal of Medical Quality 1997; 12(1): 11-18,
Eye on Improvement 1997; 4(19): 3.

5. Legorreta AP, Hasan MM, Peters AL, Pelletier KR, Leung KM. An Intervention for Enhancing Compliance With Screening Recommendations for Diabetic Retinopathy: A Bicoastal Experience. Diabetes Care 1997; 20(4): 520-523, Focus On Diabetic Retinopathy 1997; 4(3): 70-71.

6. Legorreta AP, Brooks RJ, Leibowitz AN, Solin LJ. Cost of Breast Cancer Treatment: A 4-Year Longitudinal Study. Archives of Internal Medicine 1996; 156: 2197-2201.

7. Legorreta AP, Christian-Herman J, O'Connor RD, Hasan MM, Evans R, Leung KM. Compliance With National Asthma Management Guidelines and Specialty Care: A Health Maintenance Organization Experience. Archives of Internal Medicine 1998; 158:457-464.

8. Legorreta AP, Meng Y, Leung KM, Lin Z, Davidson MB. Diabetes and Disenrollment in an HMO Setting-A Four-Year Longitudinal Study with a Matched Cohort. Diabetes Care 1999; 22(9): 1487-1489.

9. Legorreta AP, Liu X, Parker RG. Examining the Utilization of Breast-Conserving Treatment for Women With Breast Cancer in a Managed Care Environment. American Journal of Clinical Oncology: 2000; 23(5): 438-441.

10. O'Connor RD, O'Donnell JC, Pinto LA, Wang SW, Wiener DJ, Legorreta AP. Two-Year Retrospective Economic Evaluation of Three Dual-Controller Therapies Used in the Treatment of Asthma. Chest Journal. 2002;121:1028-1035.